Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Innovative STD Prevention Programs
April is National STD Awareness Month. Sexually transmitted diseases (STD) continue to be a serious health threat in
the United States. In 2000, an estimated 18.9 million persons were infected with STDs, of which half were persons aged
<25 years; direct medical costs of STDs were approximately $9.3--$15.5 billion. Despite these data, innovative STD
prevention efforts are having a positive impact on infection rates in several U.S. cities.
Because of the high prevalence of chlamydia in young women and its frequent lack of symptoms, CDC recommends
annual chlamydia screening for all sexually active women aged <25 years. However, screening levels might be low in many settings
(1). In nonmedical settings, innovative chlamydia screening and treatment efforts have been successful. For
example, a program in Philadelphia identified and treated
approximately 800 chlamydia infections among female students in city schools during
the 2002--03 school year. The intervention prevented an estimated 240 cases of pelvic
inflammatory disease and saved the health-care system an
estimated $300,000 in future treatment costs
(2).
Recent studies have shown potential for reaching sex partners through e-mail and Internet chat rooms and referring
them for STD testing and treatment (3,4). Recent data also have demonstrated the potential of "patient-delivered partner
therapy," an approach in which persons who have an STD diagnosed are given appropriate medication to provide for their sex
partners. Continued innovations, coupled with continued commitment to STD prevention and treatment by health-care
providers, health educators, public health agencies, and community leaders, are necessary to reduce the burden of STDs.
Additional information about STD prevention is available
at http://www.cdc.gov/std.
References
Burstein G, Snyder M, Conley D, et al. Screening females for Chlamydia trachomatis (CT) in a large managed care organization (MCO).
J Pediatr Adolesc Gynecol 2000;13:91.
Lawrence D, Salmon M, Asbell L, et al. An economic evaluation of a citywide school-based screening program for
Chlamydia trachomatis. Presented at the 2004 National STD Prevention Conference (P076), Philadelphia, Pennsylvania, 2004.
Constant P. Utilizing the Internet for partner notification. Presented at the 2004 National STD Prevention Conference (B09E),
Philadelphia, Pennsylvania, 2004.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
